Genor Biopharma Holdings Limited(DE:67N0)
€0.18+0.00 (+1.73%)
DE:67N0
Genor Biopharma Holdings Limited earnings date
€0.18
At close:+0.00 (+1.73%)
Genor Biopharma Holdings Limited (67N0) Q2 2026 Earnings Report
0 Followers
DE:67N0 Q2 2026 EPS Results
- Actual EPS
- EUR 0.00
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.01
DE:67N0 Q2 2026 Revenue Results
- Actual Revenue
- EUR 111.54M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +2772.44%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/28/2026
- Time
- Before Open
- Conference Call
- Friday, August 28, 2026
DE:67N0 Upcoming Earnings
Genor Biopharma Holdings Limited's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:67N0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | ―- | 0.04 | ― | ― |
| Aug 28, 2026 | 2026 (Q2) | ―-0.00 | -0.01 | 66.07% (+0.01) | |
| Mar 27, 2026 | 2025 (Q4) | ―0.04 | 0.02 | 140.38% (+0.02) | |
| Aug 29, 2025 | 2025 (Q2) | ―-0.01 | -0.03 | 55.20% (+0.02) | |
| Mar 30, 2025 | 2024 (Q4) | ―0.02 | -0.1 | 118.18% (+0.11) | |
| Aug 28, 2024 | 2024 (Q2) | ―-0.03 | -0.07 | 53.70% (+0.04) | |
| Mar 27, 2024 | 2023 (Q4) | -0.06-0.10 | -0.07 | -34.06% (-0.02) | |
| Aug 30, 2023 | 2023 (Q2) | -0.07-0.07 | -0.11 | 34.15% (+0.04) | |
| Mar 30, 2023 | 2022 (Q4) | -0.06-0.08 | -0.12 | 31.91% (+0.04) | |
| Aug 30, 2022 | 2022 (Q2) | -0.94-0.11 | -0.11 | 0.00% (+0.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

